|
|||||
|
|
|||||
| Case Report | |||||
|
|
|||||
| Volume 3, Number 4, August 2012, pages 267-269 | |||||
|
|
|||||
|
Idiopathic Hypertrophic Pachymeningitis as a Rare Cause of Spinal Cord Compression
aDepartment
of Medicine, Kingsbrook Jewish Medical Center, Brooklyn, NY 11203,
USA
Manuscript accepted for publication April 4, 2012
Abstract
Hypertrophic pachymeningitis is a chronic diffuse inflammatory
fibrosis of dural mater. We herein report a rare case of spinal cord
compression caused by idiopathic spinal hypertrophic
pachymeningitis. A 49-year-old man, with a history of HIV infection,
presented with worsening thoracic back pain and right leg pain for
one year. A continuous epidural mass from T1 to T4 and a second
ventral epidural mass at L5 were found on the MRI scan of the spine.
Laminectomy and spinal cord decompression were performed, and the
histopathology reported fibrosis with mixed inflammatory cellular
infiltrates in the dural mater without any evidence of mycobacterial
and fungal infection. The diagnosis of idiopathic spinal
hypertrophic pachymeningitis was concluded. He received steroids
therapy and recovered full neurological functions. The existing
English literature on this rare disease was reviewed and discussed. Keywords: Dural mater; Spinal cord; Fibrosis
Introduction
Spinal cord compression is a serious disease. Hypertrophic
pachymeningitis, a chronic diffuse inflammatory fibrosis of dural
mater, is an uncommon cause of spinal cord compression. This disease
was first described by Charcot and Joffroy in the 19th century, and
infections (e.g., tuberculosis, syphilis or fungi) were often the
causes in the past. We report herein a rare case of idiopathic
spinal hypertrophic pachymeningitis (ISHP) in a patient with HIV and
hepatitis B infections, and the existing literature on this disease
was reviewed. Case Report
A
49-year-old African-American man presented with thoracic back pain
and right leg pain for one year. The pain was aggravated by
prolonged walking and standing without any change in bowel and
urination habits. Past medical history was significant for HIV
infection for 10 years. The HAART therapy (Prezista, Norvir, and
Truvada) was discontinued 3 months before the presentation because
of appearance of jaundice. On physical evaluation, he had icteric
sclera and palpable liver edge that was soft and non-tender. In
addition, there was tenderness around the T3 vertebrae and decreased
range of motion at the back and right leg. Straight leg test was
positive on the right side, but strength and sensation in the
extremities remained intact.
Discussion Based on anatomic site, hypertrophic pachymeningitis can be classified into spinal form, intracranial form, and a combination of both. Because hypertrophic pachymeningitis was limited to spine in our case, the English literature on the spinal form of this disease with idiopathic etiology was reviewed. In total, fifteen cases (including our case) were found (see supplemental 1). Among these cases, the age of disease onset ranges from 28 to 68 (median age 56), and female is more common to be afflicted (male/female ratio: 6:9). Thoracic spine (14 cases) is most commonly to be affected, followed by cervical (7 cases) and lumbar spine (2 cases). Eight cases reported ISHP at more than one anatomic spinal region. The clinical presentations of ISHP include radicular pain, sensory disturbance, and muscle weakness/atrophy. Surprisingly, bladder and bowel dysfunction was not uncommon (8 cases). MRI is an important tool to differentiate hypertrophic pachymeningitis from other causes of spinal cord compression. A characteristic finding of hypertrophic pachymeningitis in MRI is thickened dura at multiple continuous spinal levels. In average, the dura of seven spinal levels (with a range of 2 - 11) were affected in the reported cases. Pai et al. proposed that a long extramedullary mass with low T2 signal intensity and peripheral enhancement (due to edema) is highly suggestive of this diagnosis [1]. The definite diagnosis still relies on pathology to demonstrate fibrosis and infiltration of inflammatory cells in dura mater. Infectious diseases (e.g., syphilis, fungi, tuberculosis) need to be ruled out in order to diagnose ISHP. The association of hypertrophic pachymeningitis with HIV and hepatitis infection as well as use of antiretroviral agents is unknown. To our knowledge, this is the first case that reports ISHP in patients with HIV and hepatitis B infection. Treatment of ISHP includes surgery and steroids. Laminectomy or laminoplasty was performed to decompress spinal cord in all reported cases. After diagnosis is confirmed by histology, the main stay of treatment is steroids. It has been reported that steroids led to dramatic reduction of symptoms and complete remission, but some patients became dependent on steroids to remain in remission [2]. No alternative treatment has yet been reported. In the patients with cranial form of hypertrophic pachymeningitis, methotrexate [3] and immunosuppressive therapy (azathioprine) [4] have been tried with good results. ISHP has 33% recurrence rate, which may still be underestimated because the length of follow-up was less than one year in many reported cases. Relapse of ISHP can be treated with steroids alone without laminectomy. It is the authors' opinion that development of new therapies is necessary and methotrexate may be tried as an alternative therapy of steroids. Conclusion
Spinal hypertrophic pachymeningitis is a chronic diffuse
inflammatory fibrosis of dural mater, with a characterized finding
of thickened dura at multiple spinal levels in MRI.
Hypertrophic pachymeningitis should be considered as a differential
diagnosis in the evaluation of spinal cord compression by an
epidural mass.
Conflicts of Interest and Source of Funding |
|||||
|
|
|||||
| References | |||||
| 1. |
Pai S, Welsh CT, Patel S, Rumboldt Z. Idiopathic
hypertrophic spinal pachymeningitis: report of two cases with typical MR
imaging findings. AJNR Am J Neuroradiol. 2007;28(3):590-592. [Medline] |
| 2. |
Claus E, Rutgers M, Sindic C, Raftopoulos C, Godfraind C,
Duprez T. Remitting/relapsing idiopathic hypertrophic spinal
pachymeningitidis: comprehensive imaging work-up and MR monitoring. Eur
Radiol. 2005;15(1):53-58. [Medline] [CrossRef] |
| 3. |
Bosman T, Simonin C, Launay D, Caron S, Destee A,
Defebvre L. Idiopathic hypertrophic cranial pachymeningitis treated by
oral methotrexate: a case report and review of literature. Rheumatol
Int. 2008;28(7):713-718. [Medline] [CrossRef] |
| 4. |
Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ.
Idiopathic hypertrophic pachymeningitis. Neurology. 2004;62(5):686-694. [Medline] |
This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Digital Object Identifier (DOI):10.4021/jmc637w
About
DOI and
CrossRef
Journal of Medical Cases is a member of CrossRef.



